
Scandinavian ChemoTech Investor Relations Material
Latest events

Status Update
Scandinavian ChemoTech

Q1 2025
6 May, 2025

Q4 2024
4 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Scandinavian ChemoTech
Access all reports
Scandinavian ChemoTech is a medical technology company specializing in innovative treatment solutions for cancer and chronic pain. The company develops and markets therapies based on its patented Tumor-Specific Electroporation (TSE) technology, designed to enhance the effectiveness of chemotherapy for specific cancers. Its products are intended to provide minimally invasive and targeted treatments.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CMOTEC
Country
🇸🇪 Sweden